Cited by 24Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyNuclear Receptors and Signaling

Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture

Open access
Radad, Khaled, Moldzio, Rudolf, Rausch, Wolf-Dieter·2015·Folia Neuropathologica

Abstract

INTRODUCTION: Parkinson's disease is the most common movement disorder, characterized by a progressive and extensive loss of dopaminergic neurons in the substantia nigra pars compacta and their terminals in the striatum. So far, only symptomatic treatment is available, and no cure or disease-modifying drugs exist. The present study was designed to investigate the neuroprotective effect of rapamycin, an autophagy inducer, on dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. MATERIAL AND METHODS: Primary mesencephalic cell cultures were prepared from embryonic mouse mesencephala (OFI/SPF, Vienna, Austria) at gestation day 14. Four sets of cultures were treated as follows: one was run as an untreated control, a second one was treated with 20 nM rotenone on the 10th day in vitro (DIV) for 48 h, a third one was co-treated with 20 nM rotenone and rapamycin (1, 10, 100, 1000 nM) on the 10th DIV for 48 h, and a fourth one was treated with rapamycin alone (1, 10, 100, 1000 nM) on the 10th DIV for 48 h. On the 12th DIV, cultures were subjected to immunohistochemistry against tyrosine hydroxylase and to fluorescence staining using LysoTracker Deep Red, JC-1 and DAPI stains. RESULTS: Exposure of such cultures to 20 nM rotenone on the 10th DIV for 48 h reduced the number of dopaminergic neurons by 41% and increased the release of lactate dehydrogenase (LDH) by 178% above untreated controls. Rapamycin (1, 10, 100, 1000 nM) added together with rotenone from the 10th to 12th DIV spared dopaminergic neurons by 17% and reduced the release of LDH by 64% at the concentration of 100 nM compared to rotenone-treated cultures. Activation of an autophagic process by rapamycin was demonstrated by LysoTracker Deep Red fluorescent dye, as indicated by a shift to increased red fluorescence. Rapamycin also significantly elevated the mitochondrial membrane potential (Δψm), as shown by an increase of the red:green fluorescence ratio of JC-1. Increased apoptotic cell death due to rotenone was lowered by rapamycin, as shown by the blue-fluorescent DAPI nucleic acid stain. CONCLUSIONS: Our study indicates for the first time that rapamycin, known as an autophagy inducer, protected dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.

Integrity signals

Registry

Crossref · 10.5114/fn.2015.54426

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rapamycin protects primary murine mesencephalic cells against rotenone-induced cell death and is accompanied by an increase in mitochondrial potential membrane.

    “Interestingly, rapamycin treatment is accompanied by an increase in mitochondrial potential membrane [100], suggesting, again, a link between mitochondrial (un)coupling and autophagy.”

The citation lists haven’t been fetched yet

References 31 · Cited by 24

Authors
Radad, K., Moldzio, R., & Rausch, W.-D.
Affiliations
  • Assiut University (EG)
  • University of Veterinary Medicine Vienna (AT)
Corresponding author
Radad, Khaled
Venue
Folia Neuropathologica
Published
2015
Volume
3
Issue
3
Pages
250-261
ISSN
  • 1509-572X (ISSN-L)
  • 1641-4640
OpenAlex
W2410861866
Cited by
24
References
31
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 1
FWCI
2.11
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Folia Neuropathologica (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
rapamycin, neuroprotection, dopaminergic neurons, rotenone, Parkinson's disease, autophagy, mitochondrial membrane potential, mitochondrial depolarization, apoptosis, tyrosine hydroxylase, lactate dehydrogenase release, autophagy induction, mitochondrial dysfunction, substantia nigra pars compacta, striatum, disease-modifying therapy
MeSH terms
Animals, Cells, Cultured, Immunosuppressive Agents, Mesencephalon, Parkinson Disease, Rotenone, Uncoupling Agents, Apoptosis, Neuroprotective Agents, Sirolimus, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review